John Maraganore, Alnylam CEO (via YouTube)

Al­ny­lam, Sarep­ta jump in­to Covid-19 game, as pan­dem­ic rekin­dles an­tivi­ral hopes of RNA-tar­get­ing tech­nol­o­gy

The idea had been there from the be­gin­ning. Sci­en­tists, study­ing plants and worms at the turn of the 21st cen­tu­ry, dis­cov­ered a mech­a­nism cells used …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.